Miami GU Oncology Summit conference hero image

Miami GU Oncology Summit

Venue: Hyatt Regency Miami, 400 Southeast 2nd Street, Miami, FL, 33131, United States

Start Date:
Register for Conference

Official conference page for Miami GU Oncology Summit.

About Miami GU Oncology Summit

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

12+

Faculty and committee

Conference program and agenda

Agenda

Saturday, November 14th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

08:00 AM - 08:05 AMWelcome
08:05 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities *This is a non-CME accredited activity*
08:30 AM - 09:45 AMSession 1: Management of newly diagnosed mAPMN (mCSPC) prostate cancer

Session Chair: Rohan Garje, MD; Michael Carducci, MD

08:30 AM - 08:40 AM

Case Presentation: The case for upfront PSMA radioligand therapy: Should Pluvicto become the first-line standard for all PSMA-positive mAPMN/S prostate cancer?

08:40 AM - 08:50 AM

Case Presentation: The case for chemotherapy intensification: When is ADT + ARPI + docetaxel the preferred first-line triplet in mAPMN/S prostate cancer?

08:50 AM - 09:05 AM

Case-Based Panel Discussion

Moderators:

Rohan Garje, MD; Michael Carducci, MD

Panelists:

Vinay Minocha, MD

09:05 AM - 09:15 AM

Case Presentation: Upfront PARP inhibition in mAPMN/S prostate cancer: Is BRCA2 the defining biomarker, and who benefits beyond it?

09:15 AM - 09:25 AM

Case Presentation: Capivasertib + abiraterone + ADT in PTEN-deficient mAPMN/S prostate cancer: Defining the ideal candidate? Jingsong Zhang, MD, PhD

09:25 AM - 09:45 AM

Case-Based Panel Discussion

Moderators:

Rohan Garje, MD; Michael Carducci, MD

Panelists:

Vinay Minocha, MD

09:45 AM - 11:00 AMSession 2: Renal cell carcinoma — State of the art

Session Chair: Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

09:45 AM - 09:55 AM

Case Presentation: The localized renal mass: Surgery, ablation, radiation, or surveillance?

09:55 AM - 10:05 AM

Case Presentation: Adjuvant therapy after nephrectomy: Who should we treat and with what?

10:05 AM - 10:20 AM

Case-Based Panel Discussion

Moderators:

Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

Panelists:

Raju Vaddepally, MD

10:20 AM - 10:30 AM

Case Presentation: Metastatic disease: Choosing first-line therapy in clear-cell non–clear-cell

10:30 AM - 10:40 AM

Case Presentation: Non–clear-cell RCC: Histology, molecular drivers, and treatment selection

10:40 AM - 11:00 AM

Case-Based Panel Discussion

Moderators:

Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

Panelists:

Raju Vaddepally, MD

11:00 AM - 11:15 AMBreak & Exhibits
11:15 AM - 12:30 PMSession 3: Bladder cancer

Session Chair: Arnab Basu, MD; Manuel Ozambela, MD

11:15 AM - 11:25 AM

Case Presentation: Choosing among options in BCG-unresponsive NMIBC

11:25 AM - 11:35 AM

Case Presentation: Perioperative systemic therapy for MIBC — a moving target

11:35 AM - 11:50 AM

Case-Based Panel Discussion

Moderators:

Arnab Basu, MD; Manuel Ozambela, MD

Panelists:

Jan Krzysztof Rudzinski, MD

11:50 AM - 12:00 PM

Case Presentation: Bladder preservation options among patients with MIBC

12:00 PM - 12:10 PM

Case Presentation: Ideal systemic therapy for metastatic urothelial carcinoma

12:10 PM - 12:30 PM

Case-Based Panel Discussion

Moderators:

Arnab Basu, MD; Manuel Ozambela, MD

Panelists:

Jan Krzysztof Rudzinski, MD

12:30 PM - 01:30 PM Lunch & Exhibits
01:30 PM - 02:45 PMSession 4: Symptom management, survivorship & well-being

01:30 PM - 01:40 PM

Case Presentation: Symptom management

01:40 PM - 01:50 PM

Case presentation: Drug interaction

01:50 PM - 02:05 PM

Case-Based Panel Discussion

02:05 PM - 02:15 PM

Case Presentation: Nurse navigator

02:15 PM - 02:25 PM

Case Presentation: Role of research coordinator in clinical trials

02:25 PM - 02:45 PM

Case-Based Panel Discussion

Venue and map

Registration and pricing

Exhibitors and sponsorship